EmergingResearch compound

Flmodafinil

Bisfluoromodafinil (CRL-40,940), roughly 3× more potent in vivo.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

WHAT IS FLMODAFINIL?

Detailed overview

Flmodafinil (CRL-40,940, lauflumide) is a bis-(p-fluoro) phenyl substituted racemic derivative of Modafinil. Animal models describe ~3× higher in vivo potency; its aqueous solubility and bioavailability are better than Modafinil`s. In clinical trials it is **better tolerated than Modafinil with fewer adrenergic-like side effects** and **less negative impact on sleep architecture** (PMC 6104159). Mechanism: atypical DAT inhibition (Methylphenidate-like profile) complemented by orexin/histamine modulation. Fewer CYP-enzyme interactions than Modafinil (PMID 38852786) → fewer drug-drug interactions. Human Phase 1 studies have been conducted but it is not an approved medicine. Banned in the UK under the Psychoactive Substances Act.

Mechanism

Modafinil-like, DAT inhibition

Half-life

Limited human data

Legal status

Investigational, not approved

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Headache, the most common modafinil-class side effect
  • Insomnia, disrupted sleep, especially with late dosing (though milder than with Modafinil)
  • Anxiety, nervousness, restlessness
  • Appetite loss, nausea, mild GI discomfort
  • Dry mouth, dizziness
  • Mildly elevated heart rate or blood pressure (fewer adrenergic effects than Modafinil)
  • Rare but serious skin reaction risk in this class (rash, Stevens-Johnson syndrome)

Contraindications · 6

  • Pregnancy and breastfeeding: safety not established, avoid
  • Cardiovascular disease, arrhythmia, uncontrolled hypertension: caution due to dopaminergic/stimulant profile
  • History of anxiety disorders: may worsen anxiety and restlessness
  • Hormonal contraception: the modafinil class may reduce its efficacy (backup method advised)
  • Prior serious skin reaction (rash, hypersensitivity) to modafinil-type agents: contraindicated
  • Experimental, unapproved compound with limited human data; extra caution with hepatic or renal impairment

Related Nootropics

Same therapeutic category

Telegram

Have a question about Flmodafinil?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.